Nitin Goel

Nitin Goel is the Head of Early Commercial for Vaccines & Immune Therapies at AstraZeneca, where they guide clinical and preclinical asset development. Previously, Nitin held leadership roles in early commercial strategy for AstraZeneca and GSK, contributing to the successful market access and branding of multiple vaccine franchises. Their earlier experience includes serving as a Bioprocess Specialist at Paragon Bioservices and a Research Specialist at Aeras Global TB Vaccine Foundation, where they developed innovative methods to enhance vaccine manufacturing processes. Nitin earned an MBA from Georgetown University's McDonough School of Business.